Association Between Polycystic Ovary Syndrome and the Polymorphisms of Aryl Hydrocarbon Receptor Repressor, Glutathione-S-transferase T1, and Glutathione-S-transferase M1 Genes

References

• Peppard HR, Marfori J, Iuorno MJ, et al. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care. 2001;24(6):1050–1052.
   PubMed Web of Science ®Google Scholar
• Chen X, Yang D, Mo Y, et al. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008;139(1):59–64.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS. Endocrine. 2006;30(1):19–26.
   PubMed Web of Science ®Google Scholar
• Barrett ES, Sobolewski M. Polycystic ovary syndrome: do endocrine disrupting chemicals play a role? Semin Reprod Med. 2014;32(03):166–176.
   PubMedGoogle Scholar
• Caserta D, Maranghi L, Mantovani A, et al. Impact of endocrine disruptor chemicals in gynaecology. Hum Reprod Update. 2008;14(1):59–72.
   PubMed Web of Science ®Google Scholar
• Darbre PD. Endocrine disruptors and obesity. Curr Obes Rep. 2017;6(1):18–27.
   PubMed Web of Science ®Google Scholar
• Gregoraszczuk EL, Ptak A. Endocrine-disrupting chemicals: some actions of POPs on female reproduction. Int J Endocrinol. 2013;2013(828532):1–9.
   Google Scholar
• Latini G, Scoditti E, Verrotti A, et al. Peroxisome proliferator-activated receptors as mediators of phthalate-induced effects in the male and female reproductive tract: epidemiological and experimental evidence. PPAR Research. 2008;2008:359267.
   PubMed Web of Science ®Google Scholar
• Newbold RR, Padilla-Banks E, Jefferson WN. Environmental estrogens and obesity. Mol Cell Endocrinol. 2009;304(1-2):84–89.
   PubMed Web of Science ®Google Scholar
• Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2007;3(2):103–111.
   PubMedGoogle Scholar
• Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):707–718.
   PubMed Web of Science ®Google Scholar
• Guerrero-Bosagna CM, Skinner MK. Environmental epigenetics and phytoestrogen/phytochemical exposures. J Steroid Biochem Mol Biol. 2014;139:270–276.
   PubMed Web of Science ®Google Scholar
• Panidis D, Tziomalos K, Papadakis E, et al. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome. Clin Endocrinol (Oxf)). 2014;80(3):432–438.
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Tsutsumi O, Ikezuki Y, et al. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J. 2004;51(2):165–169.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhao Y, Qiu X, et al. Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study. Hum Reprod. 2015;30(8):1964–1973.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi YM, Lee GH, et al. Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes. Hum Reprod. 2007;22(7):1866–1870.
   PubMed Web of Science ®Google Scholar
• Chernyak YI, Grassman JA. Impact of AhRR (565C>G) polymorphism on dioxin dependent CYP1A2 induction. Toxicol Lett. 2020;320:58–63.
   PubMed Web of Science ®Google Scholar
• Chae SJ, Kim JJ, Choi YM, et al. Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome. Gynecol Obstet Invest. 2010;70(1):1–7.
   PubMed Web of Science ®Google Scholar
• Galazis N, Pang YL, Galazi M, et al. Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration. Gynecol Endocrinol. 2013;29(7):638–644.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Choi YM, Hong MA, et al. Gene dose effect between a fat mass and obesity-associated polymorphism and body mass index was observed in Korean women with polycystic ovary syndrome but not in control women. Fertil Steril. 2014;102(4):1143–1148 e2.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Choi YM, Choung SH, et al. Estrogen receptor beta gene +1730 G/A polymorphism in women with polycystic ovary syndrome. Fertil Steril. 2010;93(6):1942–1947.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Choi YM, Cho YM, et al. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clin Endocrinol (Oxf)). 2012;77(3):439–445.
   PubMed Web of Science ®Google Scholar
• Eshre TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81:19–25.
   Web of Science ®Google Scholar
• Kim JJ, Chae SJ, Choi YM, et al. Assessment of hirsutism among Korean women: results of a randomly selected sample of women seeking pre-employment physical check-up. Hum Reprod. 2011;26(1):214–220.
   PubMed Web of Science ®Google Scholar
• Chae SJ, Kim JJ, Choi YM, et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod. 2008;23(8):1924–1931.
   PubMed Web of Science ®Google Scholar
• Zudaire E, Cuesta N, Murty V, et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest. 2008;118(2):640–650.
   PubMed Web of Science ®Google Scholar
• Monick MM, Beach SR, Plume J, et al. Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(2):141–151.
   PubMed Web of Science ®Google Scholar
• Sanada N, Gotoh Y, Shimazawa R, et al. Repression of Activated Aryl Hydrocarbon receptor-induced transcriptional activation by 5alpha-dihydrotestosterone in human prostate cancer LNCaP and human breast cancer T47D cells . J Pharmacol Sci. 2009;109(3):380–387.
   PubMed Web of Science ®Google Scholar
• Hernandez-Ochoa I, Barnett-Ringgold KR, Dehlinger SL, et al. The ability of the aryl hydrocarbon receptor to regulate ovarian follicle growth and estradiol biosynthesis in mice depends on stage of sexual maturity. Biol Reprod. 2010;83(5):698–706.
   PubMed Web of Science ®Google Scholar
• Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(1):271–276.
   PubMedGoogle Scholar
• Seidegård J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA. 1988;85(19):7293–7297.
   PubMed Web of Science ®Google Scholar
• Wu W, Lu J, Tang Q, et al. GSTM1 and GSTT1 null polymorphisms and male infertility risk: an updated meta-analysis encompassing 6934 subjects. Scientific Rep. 2013;3:2258.
   PubMed Web of Science ®Google Scholar
• Han JH, Lee HJ, Kim TS, et al. The effect of glutathione S-transferase M1 and T1 polymorphisms on blood pressure, blood glucose, and lipid profiles following the supplementation of kale (Brassica oleracea acephala) juice in South Korean subclinical hypertensive patients. Nutrition Research and Practice. 2015;9(1):49–56.
   PubMed Web of Science ®Google Scholar
• Porojan MD, Bala C, Ilies R, et al. Combined glutathione S transferase M1/T1 null genotypes is associated with type 2 diabetes mellitus. Clujul Medical. 2015;88(2):159–163.
   PubMedGoogle Scholar
• London SJ, Yuan J-M, Chung F-L, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai. China. The Lancet. 2000;356(9231):724–729.
   PubMed Web of Science ®Google Scholar